Vetoquinol SA

Paris Stock Exchange VETO.PA

Vetoquinol SA Shares (Diluted, Weighted) for the year ending December 31, 2023: 11,832,510

Vetoquinol SA Shares (Diluted, Weighted) is 11,832,510 for the year ending December 31, 2023, a 0.01% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Vetoquinol SA Shares (Diluted, Weighted) for the year ending December 31, 2022 was 11,831,588, a 0.03% change year over year.
Vetoquinol SA Shares (Diluted, Weighted) for the year ending December 31, 2021 was 11,827,762, a 0.01% change year over year.
Vetoquinol SA Shares (Diluted, Weighted) for the year ending December 31, 2020 was 11,826,157, a -0.05% change year over year.
Vetoquinol SA Shares (Diluted, Weighted) for the year ending December 31, 2019 was 11,831,824, a -0.08% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Paris Stock Exchange: VETO.PA

Vetoquinol SA

CEO	Mr. Alain Masson
IPO Date	Nov. 17, 2006
Location	France
Headquarters	Magny-Vernois
Employees	2,519
Sector	Health Care
Industries Pharmaceuticals

Description

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Key trends

Past 5 years